Sec Carbon, Limited (5304.T)
Amagasaki, JP
Headquartered in Amagasaki, Japan, Sec Carbon, Limited, established in 1934, is a leading manufacturer and global supplier of graphite electrodes, primarily utilized in steel production. Its extensive product range also encompasses SK-B graphitized cathode blocks, crucial for aluminum smelting. The company further provides specialized carbon and graphite materials catering to advanced industries such as semiconductor, aerospace, chemical, electrochemistry, machinery, and metallurgy. Additionally, Sec Carbon produces fine powders with applications spanning paints, sliding materials, metallurgical processes, and batteries. Operating under its current name since October 2006, having previously been known as SEC Corporation, the company distributes its diverse products to approximately 40 countries worldwide.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.82% | -4.18% | +3.77% | -14.10% | +10.61% | +4.57% | +24.94% | +30.88% | +85.05% | +390.00% | +404.12% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-19.5% Q1'26: +8.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-101.3% Q1'26: -742.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+21.5% ★ Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+15.9% ★ Q1'26: +13.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+6.7% ★ Q1'26: +4.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.4% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.01× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
|---|---|---|---|---|
| Revenue |
23.74B
est: 35.60B (-33.3%)
|
16.25B
est: 15.50B (+4.9%)
|
37.94B
est: 19.20B (+97.6%)
|
35.14B
est: 18.80B (+86.9%)
|
| EBITDA |
3.37B
est: 9.60B (-64.9%)
|
2.28B
est: 4.18B (-45.6%)
|
18.23B
est: 5.18B (+252.1%)
|
15.43B
est: 5.07B (+204.2%)
|
| EBIT |
529.00M
est: 7.92B (-93.3%)
|
1.02B
est: 3.45B (-70.3%)
|
16.93B
est: 4.27B (+296.3%)
|
13.82B
est: 4.18B (+230.5%)
|
| Net Income |
560.00M
est: 2.26B (-75.2%)
|
2.01B
|
11.84B
|
9.64B
|
| SGA |
2.59B
est: 3.90B (-33.6%)
|
2.08B
est: 1.70B (+22.6%)
|
3.12B
est: 2.10B (+48.2%)
|
2.97B
est: 2.06B (+44.2%)
|
| EPS |
27.28
est: 112.00 (-75.6%)
|
97.65
|
580.26
|
473.96
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-13 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-12 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-11 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-08 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-07 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis International Small Cap Equity ETF AVDS | 0.00% | 3.1K | 0.30% |
| 2 | Avantis International Equity ETF AVDE | 0.00% | 168.2K | 0.23% |
| 3 | Avantis International Small Cap Value ETF AVDV | 0.00% | 15.4K | 0.36% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hiroshi Tabata | Executive Officer & Director | — | male |
| Koh Nakajima | President & Director | — | male |
| Seiichi Iwai | Executive Officer, GM of Corporate Planning & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 5304.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
